公衆衛生86巻2号

2022年02月発行

特集 UP DATE 新型タバコ—COVID-19も絡むタバコ問題の今

喫煙の新型コロナ関連リスク

著者： 郷間厳¹

所属機関： ¹堺市立総合医療センター呼吸器疾患センター

ページ範囲：P.149 - P.160

ポイント
◆喫煙はCOVID-19の感染リスクを高めており、比較的若年者の方が喫煙者の感染リスクが上昇する可能性がある。
◆現在の喫煙はCOVID-19の重症化・死亡のリスクとなるが、高齢者の場合には喫煙関連疾患でもある慢性疾患の影響も間接的に関連することが推測された。
◆COVID-19は新たに禁煙した人を増やした一方で、長期のパンデミックの社会のストレスなどで、喫煙量増加、再喫煙も生じていた。

参考文献

1）Worldometer: COVID Live-Coronavirus Statistics.　https://www.worldometers.info/coronavirus/（2021年12月23日閲覧）

2）Talic S, et al: Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis BMJ 375: e068302, 2021

3）Gaibazzi N, et al: Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19. medRχiv: doi: https://doi.org/10.1101/2020.05.05.20092015

4）BBC News: Coronavirus: Smokers fit dey protected against Covid-19? 23/04/2020.　https://www.bbc.com/pidgin/tori-52398889（2021年12月5日閲覧）

5）BBC News Europe: Coronavirus: France bans online sales of nicotine products. 24/04/2020.　https://www.bbc.com/news/world-europe-52415793（2021年12月5日閲覧）

6）Luk TT, et al: Exposure to health misinformation about COVID-19 and increased tobacco and alcohol use: a population-based survey in Hong Kong. Tob Control 30: 696-699, 2021

7）Jacques FH, et al: Immunopathogenesis of COVID-19: Summary and Possible Interventions. Front Immunol 11: 564925, 2020

8）Farsalinos K, et al: Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol Rep 7: 658-663, 2020

9）Gonzalez-Rubio J, et al: Cytokine Release Syndrome（CRS）and Nicotine in COVID-19 Patients: Trying to Calm the Storm. Front Immunol 11: 1359, 2020

10）Vardavas CI, et al: COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis 18: 20, 2020

11）Zhao Q, et al: The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J Med Virol 92: 1915-1921, 2020

12）Zheng Z, et al: Risk factors of critical ＆ mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect 81: e16-e25, 2020

13）Patanavanich R, et al: Smoking Is Associated With COVID-19 Progression: A Meta-analysis. Nicotine Tob Res 22: 1653-1656, 2020

14）Guo FR: Active smoking is associated with severity of coronavirus disease 2019（COVID-19）: An update of a meta-analysis. Tob Induc Dis 18: 37, 2020

15）Li J, et al: Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2（SARS-CoV-2）pneumonia. Am J Infect Control 49: 82-89, 2021

16）Petrilli CM, et al: Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 369: m1966, 2020

17）Williamson EJ, et al: Factors associated with COVID-19-related death using OpenSAFELY. Nature 584: 430-436, 2020

18）Zhang JJ, et al: Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 75: 1730-1741, 2020

19）Yu T, et al: Association Between Clinical Manifestations and Prognosis in Patients with COVID-19. Clin Ther 42: 964-972, 2020

20）Zhou F, et al: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054-1062, 2020

21）Rigotti NA, et al: Cigarette Smoking and Risk Perceptions During the COVID-19 Pandemic Reported by Recently Hospitalized Participants in a Smoking Cessation Trial. J Gen Intern Med 36: 3786-3793, 2021

22）Rolland B, et al: Global Changes and Factors of Increase in Caloric/Salty Food Intake, Screen Use, and Substance Use During the Early COVID-19 Containment Phase in the General Population in France: Survey Study. JMIR Public Health Surveill 6: e19630, 2020

23）Tattan-Birch H, et al: COVID-19, smoking, vaping and quitting: a representative population survey in England. Addiction 116: 1186-1195, 2021

24）Gravely S, et al: Smokers' cognitive and behavioural reactions during the early phase of the COVID-19 pandemic: Findings from the 2020 ITC Four Country Smoking and Vaping Survey. PLoS One 16: e0252427, 2021

25）Klemperer EM, et al: Change in Tobacco and Electronic Cigarette Use and Motivation to Quit in Response to COVID-19. Nicotine Tob Res 22: 1662-1663, 2020

26）Soule EK, et al: Impacts of COVID-19 on Electronic Cigarette Purchasing, Use and Related Behaviors. Int J Environ Res Public Health 17: E6762, 2020

27）Koyama S, et al: Changes in Smoking Behavior Since the Declaration of the COVID-19 State of Emergency in Japan: A Cross-sectional Study From the Osaka Health App. J Epidemiol 31: 378-386, 2021

28）Besaratinia A, et al: The consequential impact of JUUL on youth vaping and the landscape of tobacco products: The state of play in the COVID-19 era. Prev Med Rep 22: 101374, 2021

29）Prats-Uribe A, et al: Smoking and COVID-19 Infection and Related Mortality: A Prospective Cohort Analysis of UK Biobank Data. Clin Epidemiol 13: 357-365, 2021

30）Matsushita Y, et al: Smoking and severe illness in hospitalized COVID-19 patients in Japan. Int J Epidemiol dyab254, 2021［Epub ahead of print］

31）Polack FP, et al: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 383: 2603-2615, 2020

32）Roest S, et al: BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med 384: 1968-1970, 2021

33）Arbel R, et al: BNT162b2 Vaccine Booster and Mortality Due to Covid-19. N Engl J Med 385: 2413-2420, 2021

34）Nomura Y, et al: Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine. Vaccines（Basel） 9: 1042, 2021

35）Sanchez-Ramirez DC, et al: Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis. Respir Med 171: 106096, 2020

36）Yoshikawa Y, et al: Association of Socioeconomic Characteristics With Disparities in COVID-19 Outcomes in Japan. JAMA Netw Open 4: e2117060, 2021